arrow_back Trending Legislation
Share share

Medical Device Electronic Labeling Act

This bill amends the Federal Food, Drug, and Cosmetic Act to expand the types of devices for which required labeling may be made available solely by electronic means. It replaces language restricting this practice to prescription devices in health care facilities and certain in vitro diagnostic devices with a broader category of devices (including in vitro diagnostic devices).
Key points
Allows required labeling to be made available solely by electronic means for devices, including in vitro diagnostic devices.
Removes previous restrictions that limited electronic labeling primarily to prescription devices intended for use in health care facilities or by health care professionals.
article Official text account_balance Process page notifications_active Track this Bill
gavel
Status:
Expired
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.
Additional Information
Medical Device Electronic Labeling Act
Print number: HR 3723
Sponsor: Rep. Obernolte, Jay [R-CA-23]
Process start date: 2023-05-25
System Note: Lustra is free, publicly auditable civic infrastructure, with full source code available on GitHub. You are reading sterilized legislative data, processed by our radical neutrality engine to strip political spin and retain factual mechanics. We process only official government data. Original documents remain the authoritative source, always verify them if you can.
Summarized by: gemini-3-pro-preview
Source data: api.congress.gov
AI work logs for this document launch
Summary & Status

Key Questions about Medical Device Electronic Labeling Act

A structured overview of the legislative process, official sources, status and civic context.

What is the official ID of this bill?

The official print number for this legislation is HR 3723.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2023-05-25.

What are the main provisions?

Key points include:

  • Allows required labeling to be made available solely by electronic means for devices, including in vitro diagnostic devices.
  • Removes previous restrictions that limited electronic labeling primarily to prescription devices intended for use in health care facilities or by health care professionals.

What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Obernolte, Jay [R-CA-23].

What is the latest detailed status?

The latest detailed status is: Referred to the Subcommittee on Health.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-30.

Analysis and Potential Impact of HR 3723

We don't know, that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge. Review our public AI processing logs for full transparency, and use Lustra to track active legislation for instant status push notifications.

CATEGORIES

Health